{"id":"https://genegraph.clinicalgenome.org/r/f1461ceb-3337-43d4-8fec-970719561b6fv1.0","type":"EvidenceStrengthAssertion","dc:description":" Pending. ANG was first reported in relation to autosomal dominant amyotrophic lateral sclerosis in 2004 (Greenway et al., PMID 15557516). At least 31 unique missense variants have been reported in humans, of these 16 were eligible for scoring using a minor allele frequency threshold of <0.000005 in the gnomAD v2.1.1 non-neurological conditions dataset. Evidence supporting this gene-disease relationship consists mostly of individual case reports with evidence of angiogenin expression in spinal motor neurons making up the experimental data. \nSummary of Case Level Data: 2.7 POINTS\nVariants in this gene have been reported in at least 70 probands in 21 publications (PMIDs 15557516, 16501576, 17886298, 17703939, 18087731, 18852347, 19153377, 19363631, 20577002, 21621297, 22190368, 22292798, 22292843, 22645277, 22752089, 23155438, 23228179, 28160950, 28444446, 31025543, 31432357) of which 23 probands from 6 studies (PMIDs 15557516, 16501576, 17886298, 18087731, 22190368, 22292843) contribute to the case level data score due to many of the most highly reported variants also being present at high frequencies in control datasets and gnomAD v2.1.1 non-neuro. Common functional assays demonstrating the effect of variants on the gene product included nuclear translocation, ribonuclease activity, angiogenic activity and morphology of cultured motor neurons co-cultured with angiogenin with ALS associated variants (PMIDs 17916583, 17886298, 23047679, 22292843, 31025543, 31432357). These assays were not used to increase case-level evidence as functional changes were observed in benign variants for example K41I [K17I]. Evidence of disruption to stress granule formation of variant K64I [K40I] was the only eligible functional data to increase the score of a case-level variant report (PMID 23047679).    \nSummary of Experimental Data: 0.5 POINTS\nAngiogenin is expressed in fetal and adult spinal motor neurons and endothelial cells (PMID 17886298). A phenotype rescue study was performed on SOD1 G93D mice. In this experiment it was shown that delivery of recombinant angiogenin ameliorated motor symptoms and extended lifespan. However, the phenotype was not fully rescued, and it was not clear what cellular process caused the underlying the results, so this evidence did not contribute towards the overall score (PMID 19109488).\nIn summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/f1461ceb-3337-43d4-8fec-970719561b6f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/4ee17299-56dd-40a7-8cec-9a316f3e46f2","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/4ee17299-56dd-40a7-8cec-9a316f3e46f2_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10096","date":"2022-02-08T00:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/4ee17299-56dd-40a7-8cec-9a316f3e46f2_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10096","date":"2022-04-11T08:51:47.203Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4ee17299-56dd-40a7-8cec-9a316f3e46f2_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a120706b-b8e1-406c-9391-0bf9191d159c","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a120706b-b8e1-406c-9391-0bf9191d159c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22292843","allele":{"id":"https://genegraph.clinicalgenome.org/r/62438d71-d94d-4cd2-b987-6e1a536ac05a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000014.9:g.20693676T>C (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA257418828"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/0680d343-c292-4e74-8727-040a40734196","type":"EvidenceLine","dc:description":"The gnomADv2.1.1 (non-neuro) allele frequency for this variant is above the agreed global MAF cut off 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0680d343-c292-4e74-8727-040a40734196_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501576","allele":{"id":"https://genegraph.clinicalgenome.org/r/b545aa51-786d-4fdb-8a1b-b701b9f0ac9c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001097577.3(ANG):c.208A>G (p.Ile70Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258106"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/da921a99-78f1-4dce-b7e1-bce18a73f3b7","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/da921a99-78f1-4dce-b7e1-bce18a73f3b7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18087731","allele":{"id":"https://genegraph.clinicalgenome.org/r/9528c910-84bd-4fc0-ac72-7d5b2ed7e9e1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000014.9:g.20693599T>C (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA389112457"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/64aa1c2b-a344-4ae3-8a66-b593348eea76","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/64aa1c2b-a344-4ae3-8a66-b593348eea76_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22292843","allele":{"id":"https://genegraph.clinicalgenome.org/r/4386c977-3192-437f-bc49-f484d213cfe7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000014.9:g.20694014G>A (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7083201"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/daaed0d4-3c81-46b3-919c-3f430caa70eb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/daaed0d4-3c81-46b3-919c-3f430caa70eb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"5H5Y cells subjected to stress using Sodium arsenate formed fewer stress granules than 5H5Y cells not expressing ANG. PMID 23047679","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/daaed0d4-3c81-46b3-919c-3f430caa70eb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15557516","allele":{"id":"https://genegraph.clinicalgenome.org/r/7ce9aaf4-466c-496b-8b99-3bc0a9141ce3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001097577.3(ANG):c.191A>T (p.Lys64Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258103"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/feff0384-e073-49f3-b63b-0fdef4827dd7","type":"EvidenceLine","dc:description":"The gnomADv2.1.1 (non-neuro) allele frequency for this variant is above the agreed global MAF cut off 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/feff0384-e073-49f3-b63b-0fdef4827dd7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Disruption to nuclear localization signal in PMID 23047679, shown in figure 2 an image of 5H5Y cells incubated with hANG variants.","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/feff0384-e073-49f3-b63b-0fdef4827dd7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501576","allele":{"id":"https://genegraph.clinicalgenome.org/r/7c722df5-eb1c-4567-b12a-52ace516af13","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001097577.3(ANG):c.121A>G (p.Lys41Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258094"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/abf1506e-86a6-4c13-ab7a-291db562e366","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/abf1506e-86a6-4c13-ab7a-291db562e366_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18087731","allele":{"id":"https://genegraph.clinicalgenome.org/r/77489bf8-8244-4e64-8b2f-0d42718cd74b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000014.9:g.20694010C>T (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2122140094"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8af493d0-869b-4326-baa7-9ad7033bf340","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8af493d0-869b-4326-baa7-9ad7033bf340_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18087731","allele":{"id":"https://genegraph.clinicalgenome.org/r/2f779777-c010-45be-9229-61cb543091e5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001097577.3(ANG):c.409G>A (p.Val137Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258115"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ce385150-0662-403c-af32-0d4535d3ac08","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ce385150-0662-403c-af32-0d4535d3ac08_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Disrupted nuclear localisation, lack of angiogenesis and rnase activity","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/ce385150-0662-403c-af32-0d4535d3ac08_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17886298","allele":{"id":"https://genegraph.clinicalgenome.org/r/28ecb25b-aac2-46de-b76d-09b4a41bfa56","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001097577.3(ANG):c.155G>A (p.Ser52Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258109"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/7b47d6ec-c53f-4c1f-a29a-e1c224582593","type":"EvidenceLine","dc:description":"The gnomADv2.1.1 (non-neuro) allele frequency for this variant is above the agreed global MAF cut off 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b47d6ec-c53f-4c1f-a29a-e1c224582593_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501576","allele":{"id":"https://genegraph.clinicalgenome.org/r/b545aa51-786d-4fdb-8a1b-b701b9f0ac9c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/12cbc119-665b-44c3-9af8-d3a544f84bcc","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/12cbc119-665b-44c3-9af8-d3a544f84bcc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501576","allele":{"id":"https://genegraph.clinicalgenome.org/r/7ce9aaf4-466c-496b-8b99-3bc0a9141ce3"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/3dc415b7-e438-420e-ad17-dd0742f4e52c","type":"EvidenceLine","dc:description":"MAF in gnomAD v2.1.1 non-neuro higher than agreed cut off of global MAF 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3dc415b7-e438-420e-ad17-dd0742f4e52c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional alterations were noted for the R33W ANG variant in a study by Tripolszki K, et al (PMID: 31025543). A ribonucleolytic assay in yeast tRNA showed that the R33W mutant retained only 57.4% of the ribonucleolytic activity compared to wild-type ANG. An additional assay from this study showed decreased translocation of R33W ANG into the nucleus compared to wild-type ANG. Nuclear translocation is essential for the proper function of angiogenin. Because of this, I am upgrading the score for this genetic evidence from 0.1 to 0.5","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/3dc415b7-e438-420e-ad17-dd0742f4e52c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31025543","allele":{"id":"https://genegraph.clinicalgenome.org/r/453271a9-d49b-49e8-95d0-7bbaee573651","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000014.9:g.20693733C>T (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7083150"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/573c49d4-08d2-4eaa-a850-caf733c4e944","type":"EvidenceLine","dc:description":"MAF in gnomAD v2.1.1 non-neuro higher than agreed cut off of global MAF 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/573c49d4-08d2-4eaa-a850-caf733c4e944_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31025543","allele":{"id":"https://genegraph.clinicalgenome.org/r/433ea7f7-3963-4c17-bf63-a881c5051f22","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000014.9:g.20693943G>A (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7083188"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/05e3353b-7caf-4590-b891-4179a62db039","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/05e3353b-7caf-4590-b891-4179a62db039_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19363631","allele":{"id":"https://genegraph.clinicalgenome.org/r/02526e05-9006-4940-a5cf-dec11bcdad6b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000014.9:g.20693598T>C (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA389112428"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f120f699-aa5f-4c16-9fd3-0f073b8942dc","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f120f699-aa5f-4c16-9fd3-0f073b8942dc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15557516","allele":{"id":"https://genegraph.clinicalgenome.org/r/7ce9aaf4-466c-496b-8b99-3bc0a9141ce3"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/47566d9d-d746-4d21-bee3-79f282a29ec9","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/47566d9d-d746-4d21-bee3-79f282a29ec9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22190368","allele":{"id":"https://genegraph.clinicalgenome.org/r/963d3924-2919-4f8a-bb84-94eb403812b6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000014.9:g.20693608G>A (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA389112611"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/41b35344-2b92-4300-9b58-c3189347de49","type":"EvidenceLine","dc:description":"MAF in gnomAD v2.1.1 non-neuro higher than agreed cut off of global MAF 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/41b35344-2b92-4300-9b58-c3189347de49_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31025543","allele":{"id":"https://genegraph.clinicalgenome.org/r/9b96534d-d6fa-49af-83ea-601b58d64dbf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001097577.3(ANG):c.3G>A (p.Met1Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7083113"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/7afeaaa2-f4bc-4edb-9abb-16b511e89d3d","type":"EvidenceLine","dc:description":"MAF in gnomAD v2.1.1 non-neuro higher than agreed cut off of global MAF 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7afeaaa2-f4bc-4edb-9abb-16b511e89d3d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19363631","allele":{"id":"https://genegraph.clinicalgenome.org/r/57ff1dd3-aef1-4fad-bfab-072631c4cad8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002937.5(RNASE4):c.-17-5559A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7083161"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/788cda02-9555-45b4-bb76-0c7681a8cd2c","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/788cda02-9555-45b4-bb76-0c7681a8cd2c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Loss of ribonucleolytic acid actvity PMID 25372031","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/788cda02-9555-45b4-bb76-0c7681a8cd2c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22292843","allele":{"id":"https://genegraph.clinicalgenome.org/r/58adb6a0-1b2f-454f-abd6-40562fc56404","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000014.9:g.20693701A>G (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA389114277"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/da122a33-da5a-45e5-82c6-1ff3bbbc3c26","type":"EvidenceLine","dc:description":"MAF in gnomAD v2.1.1 non-neuro higher than agreed cut off of global MAF 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/da122a33-da5a-45e5-82c6-1ff3bbbc3c26_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28444446","allele":{"id":"https://genegraph.clinicalgenome.org/r/9b96534d-d6fa-49af-83ea-601b58d64dbf"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/23d91e3d-2ccd-4062-925f-71fb0e4efef1","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/23d91e3d-2ccd-4062-925f-71fb0e4efef1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501576","allele":{"id":"https://genegraph.clinicalgenome.org/r/7ce9aaf4-466c-496b-8b99-3bc0a9141ce3"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/2ba2b63a-962b-404e-a1ba-ec51d2590cee","type":"EvidenceLine","dc:description":"MAF in gnomAD v2.1.1 non-neuro higher than agreed cut off of global MAF 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2ba2b63a-962b-404e-a1ba-ec51d2590cee_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22292798","allele":{"id":"https://genegraph.clinicalgenome.org/r/433ea7f7-3963-4c17-bf63-a881c5051f22"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/fc7409d2-2894-43f5-ba99-11fe20d4c233","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fc7409d2-2894-43f5-ba99-11fe20d4c233_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"From PMID 23047679, when C19 cells are differentiated into motor neurons with hANG-H114R in co-culture there are reduced numbers of motor neurons","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/fc7409d2-2894-43f5-ba99-11fe20d4c233_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18087731","allele":{"id":"https://genegraph.clinicalgenome.org/r/d22577f8-d357-42f0-a22e-1c2ec2381805","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000014.9:g.20693977A>G (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA389117482"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/578689d7-27a2-4f38-a531-719ed85b6f4c","type":"EvidenceLine","dc:description":"MAF in gnomAD v2.1.1 non-neuro higher than agreed cut off of 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/578689d7-27a2-4f38-a531-719ed85b6f4c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Lack of angiogenesis and rnase activity ","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/578689d7-27a2-4f38-a531-719ed85b6f4c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17886298","allele":{"id":"https://genegraph.clinicalgenome.org/r/df12b3f2-8538-40b8-9cdd-5f3fe03a6a24","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001097577.3(ANG):c.122A>T (p.Lys41Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258091"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/37755c9e-af31-49ba-93b4-a733ee5faf90","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/37755c9e-af31-49ba-93b4-a733ee5faf90_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18087731","allele":{"id":"https://genegraph.clinicalgenome.org/r/2f779777-c010-45be-9229-61cb543091e5"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/27f6aa15-47cf-43ed-997f-a80c327a9f71","type":"EvidenceLine","dc:description":"MAF in gnomAD v2.1.1 non-neuro higher than agreed cut off of global MAF 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/27f6aa15-47cf-43ed-997f-a80c327a9f71_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23228179","allele":{"id":"https://genegraph.clinicalgenome.org/r/57ff1dd3-aef1-4fad-bfab-072631c4cad8"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/dfcb4e0b-8eb2-4ea3-8e5a-3c1d68d2b048","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dfcb4e0b-8eb2-4ea3-8e5a-3c1d68d2b048_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501576","allele":{"id":"https://genegraph.clinicalgenome.org/r/7ce9aaf4-466c-496b-8b99-3bc0a9141ce3"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/445cc552-785c-420a-ad31-ccd7b8a22634","type":"EvidenceLine","dc:description":"The gnomADv2.1.1 (non-neuro) allele frequency for this variant is above the agreed global MAF cut off 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/445cc552-785c-420a-ad31-ccd7b8a22634_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Disruption to nuclear localization signal in PMID 23047679, shown in figure 2 an image of 5H5Y cells incubated with hANG variants.","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/445cc552-785c-420a-ad31-ccd7b8a22634_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501576","allele":{"id":"https://genegraph.clinicalgenome.org/r/7c722df5-eb1c-4567-b12a-52ace516af13"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ab664190-6d24-40cb-93ba-782f1be138ff","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ab664190-6d24-40cb-93ba-782f1be138ff_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22190368","allele":{"id":"https://genegraph.clinicalgenome.org/r/3a9c03a1-84d8-4fcc-9b70-fdb818e07e17","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000014.9:g.20693874A>T (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA389116235"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/477b165a-a279-41b8-8435-651142c80d1f","type":"EvidenceLine","dc:description":"MAF in gnomAD v2.1.1 non-neuro higher than agreed cut off of global MAF 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/477b165a-a279-41b8-8435-651142c80d1f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Reduced ribonucleic acid activity, reduced angiogenesis and reduced nuclear localiations","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/477b165a-a279-41b8-8435-651142c80d1f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31432357","allele":{"id":"https://genegraph.clinicalgenome.org/r/b943573b-2825-46b7-95f9-62eb4fe9cb94","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000014.9:g.20693697C>G (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7083144"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/dd2d89cd-333c-4ae9-a49c-d896a249baf5","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dd2d89cd-333c-4ae9-a49c-d896a249baf5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501576","allele":{"id":"https://genegraph.clinicalgenome.org/r/81be28a9-8b5e-4310-96ff-4531c772d8e3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001097577.3(ANG):c.164G>A (p.Arg55Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258097"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4a07fde0-52a4-4e29-8106-eadb7e7b1acc","type":"EvidenceLine","dc:description":"High frequency in gnomAD v2.1.1 non-neuro","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4a07fde0-52a4-4e29-8106-eadb7e7b1acc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Nuclear localisation assay and MN culture assay","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/4a07fde0-52a4-4e29-8106-eadb7e7b1acc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19153377","allele":{"id":"https://genegraph.clinicalgenome.org/r/df12b3f2-8538-40b8-9cdd-5f3fe03a6a24"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/90035b34-da5a-43ac-857f-70297025ec7f","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/90035b34-da5a-43ac-857f-70297025ec7f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Fewer motor neurons in C19 differentiated cell cultures as identified by staining Islet 1 and Periferin. Figure 3 PMID 23047679","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/90035b34-da5a-43ac-857f-70297025ec7f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501576","allele":{"id":"https://genegraph.clinicalgenome.org/r/39996807-6bef-4841-b3b5-825b2395444c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001097577.3(ANG):c.189C>G (p.Cys63Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258100"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/90397628-b333-4025-8f24-fe4e97903991","type":"EvidenceLine","dc:description":"MAF in gnomAD v2.1.1 non-neuro higher than agreed cut off of 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/90397628-b333-4025-8f24-fe4e97903991_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18087731","allele":{"id":"https://genegraph.clinicalgenome.org/r/9b96534d-d6fa-49af-83ea-601b58d64dbf"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/61d0cd22-8e60-462d-a245-0a56913c3588","type":"EvidenceLine","dc:description":"MAF higher than agreed cut off of 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/61d0cd22-8e60-462d-a245-0a56913c3588_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17886298","allele":{"id":"https://genegraph.clinicalgenome.org/r/578b0335-eda0-4b06-a825-3faca5ec814d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001097577.3(ANG):c.61C>T (p.Pro21Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7083131"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/7df4c9a7-1e87-437e-a01a-28e6b8780458","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7df4c9a7-1e87-437e-a01a-28e6b8780458_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Fewer motor neurons in C19 differentiated cell cultures as identified by staining Islet 1 and Periferin. Figure 3 PMID 23047679","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/7df4c9a7-1e87-437e-a01a-28e6b8780458_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501576","allele":{"id":"https://genegraph.clinicalgenome.org/r/39996807-6bef-4841-b3b5-825b2395444c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/7a6e16b3-83b4-420b-8496-ee79c55f60d7","type":"EvidenceLine","dc:description":"The gnomADv2.1.1 (non-neuro) allele frequency for this variant is above the agreed global MAF cut off 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7a6e16b3-83b4-420b-8496-ee79c55f60d7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501576","allele":{"id":"https://genegraph.clinicalgenome.org/r/df12b3f2-8538-40b8-9cdd-5f3fe03a6a24"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/5629b4e2-5210-4c9c-aee2-511a1e4979a2","type":"EvidenceLine","dc:description":"The gnomADv2.1.1 (non-neuro) allele frequency for this variant is above the agreed global MAF cut off 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5629b4e2-5210-4c9c-aee2-511a1e4979a2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22190368","allele":{"id":"https://genegraph.clinicalgenome.org/r/e0c89398-8480-42a4-a80a-5bbd98f2c7c5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000014.9:g.20693934T>A (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7083186"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/0eb85e5b-c625-4b52-9119-dc01aec89689","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0eb85e5b-c625-4b52-9119-dc01aec89689_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22752089","allele":{"id":"https://genegraph.clinicalgenome.org/r/2083e5c0-8c18-411e-b870-230638815560","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000014.9:g.20693622C>T (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA389112735"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/523fe822-b2ce-4aff-a1f2-15f0e252bee5","type":"EvidenceLine","dc:description":"MAF in gnomAD v2.1.1 non-neuro higher than agreed cut off of 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/523fe822-b2ce-4aff-a1f2-15f0e252bee5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Disruption to nuclear localisation, lack of angiogenesis,","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/523fe822-b2ce-4aff-a1f2-15f0e252bee5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17886298","allele":{"id":"https://genegraph.clinicalgenome.org/r/07ca45d0-cec5-404b-908b-2c07cc30c4a3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001097577.3(ANG):c.407C>T (p.Pro136Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258112"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/4146e9a7-0a72-4db2-92f0-576f3e75b597","type":"EvidenceLine","dc:description":"The gnomADv2.1.1 (non-neuro) allele frequency for this variant is above the agreed global MAF cut off 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4146e9a7-0a72-4db2-92f0-576f3e75b597_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22190368","allele":{"id":"https://genegraph.clinicalgenome.org/r/e915db09-5a8b-415b-a543-ae0a6e528975","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000014.9:g.20693623C>A (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA389112741"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c5dd8c2f-fae9-48fe-abdd-899f7b08f72a","type":"EvidenceLine","dc:description":"MAF in gnomAD v2.1.1 non-neuro higher than agreed cut off of 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c5dd8c2f-fae9-48fe-abdd-899f7b08f72a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18087731","allele":{"id":"https://genegraph.clinicalgenome.org/r/2083e5c0-8c18-411e-b870-230638815560"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/1d0480aa-7111-4822-b19a-d03b0d94994a","type":"EvidenceLine","dc:description":"The gnomADv2.1.1 (non-neuro) allele frequency for this variant is above the agreed global MAF cut off 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1d0480aa-7111-4822-b19a-d03b0d94994a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501576","allele":{"id":"https://genegraph.clinicalgenome.org/r/df12b3f2-8538-40b8-9cdd-5f3fe03a6a24"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/b4f911e9-c0a2-4ee6-8daf-2aa3b6a51741","type":"EvidenceLine","dc:description":"MAF in gnomAD v2.1.1 non-neuro higher than agreed cut off of 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b4f911e9-c0a2-4ee6-8daf-2aa3b6a51741_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"C19 cells co-cultured with hANG-R121H differentiate into fewer motor neurons (PMID 23047679)","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/b4f911e9-c0a2-4ee6-8daf-2aa3b6a51741_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18852347","allele":{"id":"https://genegraph.clinicalgenome.org/r/fcbf4c94-ab80-45cc-a836-40940f9766c5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000014.9:g.20693998G>A (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7083195"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/8fe4fb8c-5c59-4846-82f4-8a37ab3fd1c4","type":"EvidenceLine","dc:description":"Downgraded to avoid counting function information twice","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8fe4fb8c-5c59-4846-82f4-8a37ab3fd1c4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"(C19 cells differentiated as neurons cultured with variant hANG showed reduced pathfinding and neurite growth.)","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/8fe4fb8c-5c59-4846-82f4-8a37ab3fd1c4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501576","allele":{"id":"https://genegraph.clinicalgenome.org/r/4a304d6b-167f-4112-bb0c-6f3510e4a19e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001097577.3(ANG):c.107A>T (p.Gln36Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA258088"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/294d35f1-3ed0-46a1-8925-cc1e776c9181","type":"EvidenceLine","dc:description":"The gnomADv2.1.1 (non-neuro) allele frequency for this variant is above the agreed global MAF cut off 0.000005","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/294d35f1-3ed0-46a1-8925-cc1e776c9181_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501576","allele":{"id":"https://genegraph.clinicalgenome.org/r/b545aa51-786d-4fdb-8a1b-b701b9f0ac9c"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/314ef490-080d-469a-a5a8-d3ba138b5e80","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/314ef490-080d-469a-a5a8-d3ba138b5e80_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"C19 cells differentiated as neurons culturd with variant hANG showed reduced pathfinding and neurite growth.","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/314ef490-080d-469a-a5a8-d3ba138b5e80_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16501576","allele":{"id":"https://genegraph.clinicalgenome.org/r/4a304d6b-167f-4112-bb0c-6f3510e4a19e"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":2.7},{"id":"https://genegraph.clinicalgenome.org/r/4ee17299-56dd-40a7-8cec-9a316f3e46f2_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4ee17299-56dd-40a7-8cec-9a316f3e46f2_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1652b70a-5712-45ca-9efa-6ff53a63a3f3","type":"EvidenceLine","dc:description":"The rescue is not a typical rescue experiment in that it was not an ANG null mouse where the phenotype was rescued through angiogenin delivery. In addition, the phenotype was not fully recused but improved.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f2463d48-3b62-43aa-98eb-46d4866910ad","type":"Finding","dc:description":"Survival was lengthened in SOD1 mice that received recombinant angiogenin and motor neuron numbers increased","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19109488","rdfs:label":"Recombinant angiogenin delivery to G93D SOD1 mice","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/3ba70069-d8c1-4324-858a-7a0b97a4ca4b","type":"EvidenceLine","dc:description":"Not clear that there is a big difference between WT ANG and the variants, and there is some heterogeneity in variant effect. In addition, itâ€™s rescue from an induced injury, and the wide error bars made the differences in effect hard to interpret.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c28e1a55-cfe5-4314-9eeb-4e8ed9594685","type":"Finding","dc:description":"Lower level of neurodegeneration in cells co-cultured with WT-ANG compared to ALS implicated variants.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17916583","rdfs:label":"Hypoxia induced motor neuron degeneration","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityCellCultureRescueCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/4ee17299-56dd-40a7-8cec-9a316f3e46f2_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3f6a892a-a29d-4ea5-8077-0fa993d96ed0","type":"EvidenceLine","dc:description":"Decisions by GCEP to ad to case-level variant scoring","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b0686877-6630-49a6-949e-feab0664a1d8","type":"Finding","dc:description":"PMID: 27256390","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23047679","rdfs:label":"Stress granule formation","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/975e786b-a978-4a7b-80d6-d781413992b1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d36d566d-03f2-4414-9e93-5fdc67510332","type":"Finding","dc:description":"strong ANG staining was also detected in the extracellular matrix and interstitial tissues of all cases, consistent with ANG being a secreted protein. Additionally, ANG was shown to colocalize with von Willebrand factor in the blood vessels of both prenatal and adult spinal cords. These results suggest that ANG also may mediate angiogenesis in the spinal cord and may play a role in maintaining the physiological health of motor neurons. Thus, ANG abnormalities may have a dual role in ALS: directly through motor neuron function and/or indirectly through endothelial cells and aberrant angiogenesis.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17886298","rdfs:label":"ANG in Autopsy-Derived, Normal Spinal Cord ","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0.5}],"evidenceStrength":"Limited","sequence":4205,"specifiedBy":"GeneValidityCriteria8","strengthScore":3.2,"subject":{"id":"https://genegraph.clinicalgenome.org/r/yFQul4uHfkc","type":"GeneValidityProposition","disease":"obo:MONDO_0012753","gene":"hgnc:483","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_4ee17299-56dd-40a7-8cec-9a316f3e46f2-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}